- Home
- XZO vs QURE Comparison
XZO vs QURE Comparison
Compare XZO & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XZO | QURE |
|---|---|---|
| Founded | 2012 | 1998 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.9B |
| IPO Year | 2025 | 2007 |
Fundamental Metrics
Financial Performance| Metric | XZO | QURE |
|---|---|---|
| Price | $17.28 | $21.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 13 |
| Target Price | $27.00 | ★ $62.33 |
| AVG Volume (30 Days) | 224.7K | ★ 2.8M |
| Earning Date | 12-10-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.45 | N/A |
| Revenue | ★ $183,708,000.00 | $15,751,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $158.05 |
| P/E Ratio | $38.85 | ★ N/A |
| Revenue Growth | ★ 302.33 | N/A |
| 52 Week Low | $12.92 | $7.02 |
| 52 Week High | $21.75 | $71.50 |
Technical Indicators
Market Signals| Indicator | XZO | QURE |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 27.73 |
| Support Level | N/A | $20.55 |
| Resistance Level | N/A | $28.50 |
| Average True Range (ATR) | 0.00 | 1.96 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 0.00 | 11.91 |
Price Performance
Historical ComparisonAbout XZO Exzeo Group Inc. Common Stock
Exzeo Group Inc provides turnkey insurance technology and operations solutions to insurance carriers and their agents based on a proprietary platform of purpose-built software and data analytics applications that are specifically designed for the property and casualty, or P&C, insurance ecosystem. Its Insurance-as-a-Service (IaaS) platform, which it refers to as the Exzeo Platform, currently includes nine configurable software and data analytics applications that are purpose-built to serve insurance companies and other customers in the insurance value chain. Through the Exzeo Platform, the company provides technology-based solutions and services for all operational and administrative activities and functions needed by P&C insurance carriers and their agents.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.